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Abstract Prions are self-propagating protein aggregates that are characteristically transmissible. 
In mammals, the PrP protein can form a prion that causes the fatal transmissible spongiform 
encephalopathies. Prions have also been uncovered in fungi, where they act as heritable, protein-
based genetic elements. We previously showed that the yeast prion protein Sup35 can access the 
prion conformation in Escherichia coli. Here, we demonstrate that E. coli can propagate the Sup35 
prion under conditions that do not permit its de novo formation. Furthermore, we show that 
propagation requires the disaggregase activity of the ClpB chaperone. Prion propagation in yeast 
requires Hsp104 (a ClpB ortholog), and prior studies have come to conflicting conclusions about 
ClpB's ability to participate in this process. Our demonstration of ClpB-dependent prion 
propagation in E. coli suggests that the cytoplasmic milieu in general and a molecular machine in 
particular are poised to support protein-based heredity in the bacterial domain of life.
DOI: 10.7554/eLife.02949.001
Introduction
Prions are infectious, self-propagating protein aggregates first described in the context of scrapie 
(Prusiner, 1982), an example of a class of devastating neurodegenerative diseases known as the trans-
missible spongiform encephalopathies (TSEs). Specifically, the prion form of a protein known as PrP is 
the causative agent of the TSEs, which afflicts humans and other mammals. Native PrP (PrPC) under-
goes a dramatic change in conformation upon conversion to its prion form (PrPSc), forming distinctive 
cross-β aggregates termed as amyloid (Diaz-Espinoza and Soto, 2012). Highly resistant to denaturation 
and proteolysis, PrPSc is infectious and templates the conformational conversion of PrPC molecules 
(Caughey et al., 2009).
Prion-like phenomena have also been described in budding yeast and other fungi. Since Wickner 
first invoked prions to account for two examples of non-Mendelian genetic elements in Saccharomyces 
cerevisiae (Cox, 1965; Aigle and Lacroute, 1975; Wickner, 1994), the study of fungal prion proteins 
has resulted in profound advances in the understanding of prion biology, including the first demon-
stration that purified prion protein aggregates are infectious (Maddelein et al., 2002; King and Diaz-
Avalos, 2004; Tanaka et al., 2004). In general, such prion proteins exist in either a native, soluble form 
or a self-perpetuating, amyloid form with spontaneous conversion between forms representing a rare 
event (Allen et al., 2007; Lancaster et al., 2010). However, unlike PrPSc, yeast prions do not normally 
cause cell death. Instead, they can act as protein-based genetic elements that confer new phenotypes 
on those cells that harbor them (True and Lindquist, 2000; Tuite and Serio, 2010; Newby and 
Lindquist, 2013). Fungal prion proteins have been found to participate in diverse cellular processes 
(Coustou et al., 1997; True et al., 2004; Suzuki et al., 2012; Holmes et al., 2013). The conversion of 
these proteins to their prion forms typically results in a dominant loss-of-function phenotype (Cox, 
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1965; Aigle and Lacroute, 1975). A particularly well-characterized example involves the essential 
translation release factor Sup35, which confers on cells a heritable nonsense suppression phenotype 
upon conversion to the prion form (Cox, 1965; Ter-Avanesyan et al., 1994; Patino et al., 1996; 
Paushkin et al., 1996).
Like other yeast prion proteins, Sup35 has a modular structure with a distinct prion domain (PrD) 
that mediates conversion to the prion form, [PSI+]. In the case of Sup35, the essential prion determi-
nants, which include a glutamine- and asparagine-rich segment and five complete copies of an imper-
fect oligopeptide repeat sequence, lie in the N-terminal domain (N), whereas translation release 
activity resides in the C-terminal domain (C) (Ter-Avanesyan et al., 1993). A highly charged middle 
region (M) increases the solubility of native Sup35 and enhances the mitotic stability of [PSI+] (Liu 
et al., 2002). Together, Sup35 N and M function as a transferable prion-forming module (NM) that 
maintains its prionogenic potential when fused to heterologous proteins (Li and Lindquist, 2000). A 
distinctive property of the Sup35 conversion process in yeast is its dependence on the presence of a 
pre-existing prion, designated [PIN+] for [PSI+] inducibility factor (Derkatch et al., 1997). Thus, yeast 
strains containing Sup35 in the non-prion form, [psi–], support the spontaneous conversion to [PSI+] 
only if they contain [PIN+], typically the prion form of the Rnq1 protein (Derkatch et al., 2000). 
However, several other yeast prion proteins, including the New1 protein, have the capacity to function 
as [PIN+] in their prion forms (Derkatch et al., 2001; Osherovich and Weissman, 2001).
Importantly, the stable propagation of yeast prions—and thus, the heritability of their associated 
phenotypes—depends on the function of chaperone proteins (Chernoff et al., 1995). Specifically, 
the AAA+ disaggregase Hsp104 is strictly required for the propagation of virtually all yeast prions 
eLife digest Unlike most infectious agents—such as viruses or bacteria—that contain genetic 
material in the form of DNA or RNA, a prion is simply an aggregate of misfolded proteins. Although 
they are not living organisms, these prion aggregates can self-propagate; when they enter a healthy 
organism, they cause existing, correctly folded proteins to adopt the prion fold. Within the 
aggregate, the prion proteins have a corrugated structure that allows them to stack together 
tightly, which in turn makes the aggregates very stable. As more prions are formed, they then 
trigger other protein molecules to misfold and join the aggregates, and the aggregates continue to 
grow and spread within the infected organism causing tissue damage and cell death.
Prion diseases are well known in mammals, where the prion aggregates typically destroy tissue 
within the brain or nervous system. Bovine spongiform encephalopathy (also commonly known as 
BSE or ‘mad cow disease’) is an example of a prion disease that affects cattle and can be 
transmitted to humans by eating infected meat. Prions also form in yeast and other fungi. These 
prions, however, do not cause disease or cell death; instead, yeast prions act as protein-based 
elements that can be inherited over multiple generations and which provide the yeast with new 
traits or characteristics. Although prions can form spontaneously in yeast cells, their stable 
propagation depends on so-called chaperone proteins that help to remodel the prion aggregates. 
Previous work has shown that bacterial cells can also support the formation of prion-like 
aggregates. The bacteria were engineered to produce two yeast prion proteins—one of which 
spontaneously formed aggregates that were needed to trigger the conversion of the other to its 
prion form. However, it was not known if bacterial cells could support the stable propagation of 
prions if the initial trigger for prion conversion was removed.
Yuan et al. now reveal that the bacterium Escherichia coli can propagate a yeast prion for over a 
hundred generations, even when the cells can no longer make the protein that serves as the trigger 
for the initial conversion. This propagation depends on a bacterial chaperone protein called ClpB, 
which is related to another chaperone protein that is required for stable prion propagation in yeast. 
As such, the findings of Yuan et al. raise the possibility that, even though a prion specific to bacteria 
has yet to be identified, prions or prion-like proteins might also contribute to the diversity of traits 
found in bacteria. Furthermore, since both yeast and bacteria form and propagate prions in similar 
ways, such protein-based inheritance might have evolved in these organisms' common ancestor 
over two billion years ago.
DOI: 10.7554/eLife.02949.002Microbiology and infectious disease
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characterized thus far, and several other chaperone proteins have been implicated in this process as 
well (Liebman and Chernoff, 2012; Winkler et al., 2012). Various lines of evidence support the view 
that the essential role of Hsp104 with respect to prion propagation stems from its ability to fragment 
prion aggregates and thereby to generate smaller seed particles known as propagons that can be 
efficiently partitioned to daughter cells during cell division (Paushkin et al., 1996; Ness et al., 
2002; Cox et al., 2003; Kryndushkin et al., 2003; Satpute-Krishnan et al., 2007; Higurashi et al., 
2008). Accordingly, depletion or inhibition of Hsp104 in a prion-containing cell leads to prion loss in 
progeny cells.
The molecular processes underlying prion biology constitute at least two distinct phases, namely, 
(i) the de novo conversion of a protein from its native to prion form, and (ii) the subsequent propaga-
tion of the self-perpetuating prion form over multiple generations. While studies have demonstrated 
that the bacterial cytoplasm can support the de novo formation of prion-like aggregates (Sabaté   
et al., 2009; Fernándes-Tresguerres et al., 2010; Garrity et al., 2010; Espargaró et al., 2012; 
Gasset-Rosa et al., 2014), evidence for prion propagation—and thus, protein conformation-dependent 
heredity—in bacteria has remained elusive. We previously demonstrated that conversion of Sup35 NM 
to its prion form in Escherichia coli, as in S. cerevisiae, depends on [PIN+], which is formed by providing 
the bacterial cells with the yeast New1 protein (Garrity et al., 2010). This [PIN+] dependence provides 
an experimental framework for distinguishing between the initial conversion and subsequent 
propagation phases of the prion cycle. In particular, the formation of prion-like Sup35 NM aggregates 
can be induced in bacterial cells containing the New1 protein; subsequent depletion of the New1 
protein from these cells reveals whether or not the bacterial cytoplasm can support the propagation 
of the Sup35 NM prion in the absence of [PIN+].
Here we show that bacteria can propagate the Sup35 prion in an infectious conformation over at 
least ∼100 generations under conditions that do not permit de novo prion formation. More specifically, 
we demonstrate maintenance of the Sup35 NM prion over multiple rounds of restreaking in E. coli 
cells no longer capable of synthesizing the New1 protein. Furthermore, we establish that propagation 
of the Sup35 NM prion in E. coli requires the disaggregase activity of ClpB, the bacterial ortholog of 
Hsp104. The striking parallel between the requirements for both prion formation and prion propaga-
tion in yeast and bacteria, which are thought to have diverged more than 2.2 billion years ago, 
suggests that the paradigm of protein-based heredity may be more ancient than previously inferred 
(DeSantis et al., 2012).
Results
E. coli cells can propagate SDS-stable Sup35 NM aggregates
Having previously shown that Sup35 NM can adopt an infectious amyloid conformation in the E. coli 
cytoplasm (Garrity et al., 2010), we wished to determine whether or not E. coli cells could stably 
propagate Sup35 NM in its prion form. To address this question, we took advantage of the fact that 
conversion of Sup35 NM to its prion conformation in E. coli depends on the presence of New1, 
mirroring features of the [PIN+] dependence of Sup35 prion formation in S. cerevisiae (Figure 1A). 
Thus, our plan was to induce the formation of infectious Sup35 NM aggregates in E. coli cells containing 
the prionogenic module of New1 and then to monitor the fate of Sup35 NM over multiple generations 
after curing the cells of New1-encoding DNA.
To facilitate these experiments, we fused Sup35 NM and New1 to two monomeric fluorescent 
proteins (mCherry bearing a C-terminal hexahistidine tag and mGFP, respectively). The two fusion 
proteins were produced from compatible plasmids under the control of IPTG-inducible promoters. 
The plasmid encoding New1-mGFP (pSC101TS-NEW1) bore a temperature-sensitive origin of replica-
tion, enabling us to cure cells of New1-encoding DNA and thereby deplete cells of the New1 fusion 
protein. As an initial test of our experimental system, we introduced the plasmid encoding Sup35 
NM-mCherry-His6x (pBR322-SUP35 NM) together with either pSC101TS-NEW1 or an empty vector con-
trol (pSC101TS) into E. coli cells and induced the synthesis of the fusion proteins at the permissive 
temperature. After overnight growth, we detected SDS-stable Sup35 NM aggregates (‘Materials and 
methods’) only in cells producing the New1 fusion protein (Figure 1B). As New1 can independently 
adopt an amyloid conformation in E. coli (Garrity et al., 2010), we also detected SDS-stable New1 
aggregates in cells containing both fusion proteins (Figure 1B). Western blot analysis revealed that the 
intracellular levels of the Sup35 NM fusion protein were comparable in the presence and absence of Microbiology and infectious disease
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Figure 1. Conversion of Sup35 NM to its prion form in E. coli requires New1. (A) Cartoon representation of how 
conversion of soluble Sup35 NM (Sup35soluble) to its amyloid conformation (Sup35amyloid) depends on the presence of 
New1 in its amyloid conformation (New1amyloid). Sup35 NM and New1 (black) are depicted as fusions to mCherry 
(red) and mGFP (green), respectively. (B) SDS-stable Sup35 NM aggregates are detected only in cells producing 
SDS-stable New1 aggregates as assessed by filter retention analysis. For each sample, undiluted lysate and three 
twofold dilutions are shown (see ‘Materials and methods’). Sup35 NM and New1 aggregates are no longer 
detected once boiled. The α-Sup35 antibody recognizes the Sup35 NM-mCherry-His6X fusion protein, and the 
α-GFP antibody detects the New1-mGFP fusion protein. (C) Intracellular full-length (FL) Sup35 NM fusion protein 
levels are comparable in the presence and absence of New1 as assessed by Western blot analysis. The α-RpoA 
antibody recognizes the α subunit of E. coli RNA polymerase. (D) Fluorescence images of representative cells 
containing Sup35 NM and New1 or Sup35 NM alone. For cells containing both fusion proteins, the mCherry 
channel, GFP channel, and merged images are shown.
DOI: 10.7554/eLife.02949.003
The following figure supplement is available for figure 1:
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the New1 fusion protein (Figure 1C, Figure 1—figure supplement 1A). We also examined cells by 
fluorescence microscopy. In cells containing both fusion proteins, Sup35 NM formed twisted ring 
structures (Garrity et al., 2010) or large polar foci in 22.5% of cells (N = 258), whereas New1 formed 
punctate foci in 89.8% of cells (N = 258). (Figure 1D). In contrast, Sup35 NM exhibited diffuse fluores-
cence in 100% of cells lacking New1 (N = 532) (Figure 1D).
We then sought to determine whether or not E. coli cells could propagate SDS-stable Sup35 NM 
aggregates over multiple generations under conditions that do not permit the de novo formation of 
aggregates (that is, in the absence of New1). Our experimental protocol is illustrated in Figure 2 (see 
also Figure 3A). We first induced fusion protein synthesis in cells transformed with pBR322-SUP35 NM 
and either pSC101TS-NEW1 (experimental sample) or pSC101TS (control sample). These ‘starter cul-
tures’ were grown overnight to allow for the formation of SDS-stable Sup35 NM aggregates in the 
experimental sample. The cells were then plated and grown at the non-permissive temperature to cure 
the cells of pSC101TS-NEW1 or pSC101TS, thereby generating a set of Round 1 (R1) colonies. 20 R1 
experimental colonies and 20 R1 control colonies were subsequently examined; each was (a) patched 
onto selective medium to test for loss of pSC101TS-NEW1 or pSC101TS, (b) restreaked to generate 
Round 2 (R2) colonies, and (c) inoculated into liquid medium for overnight growth to test for the pres-
ence of SDS-stable Sup35 NM aggregates. Four separate experimental lineages (L1E–L4E) originating 
from ancestral R1 experimental colonies containing detectable Sup35 NM aggregates along with four 
separate control lineages (L1C–L4C) originating from ancestral R1 control colonies were then followed 
through Round 3 (R3) and Round 4 (R4). For R2 and each subsequent round, 10 experimental colonies 
and 10 control colonies were analyzed.
All R1 experimental and control colonies (20 of each) had lost pSC101TS-NEW1 or pSC101TS, 
respectively, as assessed by patching on selective medium (data not shown). Moreover, the absence of 
NEW1 DNA was confirmed by PCR (Figure 3C) and the absence of New1 protein was confirmed by 
Western blot analysis (Figure 3B). We detected SDS-stable Sup35 NM aggregates in 8 of 20 experi-
mental samples (Figure 3B) and none of the control samples (Figure 3D). We selected 4 of the 8 
aggregate-positive clones (Figure 3B, asterisks) to establish the four experimental lineages and arbi-
trarily selected four aggregate-negative control clones (Figure 3D, asterisks) to establish the four 
control lineages. 2 of the 4 experimental lineages (L1E and L3E) retained SDS-stable Sup35 NM aggre-
gates throughout the course of the experiment (Figure 4A, Figure 4—figure supplement 1B). Of 
these two lineages, one maintained aggregates in 9 of 10 R4 clones (Figure 4A) and the other main-
tained aggregates in 7 of 10 R4 clones (Figure 4—figure supplement 1B). We conclude that SDS-
stable Sup35 NM aggregates can be propagated in E. coli for at least ∼100 generations in the absence 
of New1 (Figure 5A).
The remaining two experimental lineages (L2E and L4E) lost detectable SDS-stable Sup35 NM 
aggregates at R3 and R4, respectively (Figure 4—figure supplement 1A,C, Figure 5A). Moreover, the 
loss of aggregates manifested itself in all ten of the selected colonies at either R3 or R4 (Figure 4—
figure supplement 1A,C, Figure 5A). Curiously, the loss of SDS-stable Sup35 NM aggregates from a 
particular lineage coincided with a loss of detectable fusion protein, as assessed by Western blot 
analysis (Figure 4—figure supplement 1A,C), suggesting that the loss of aggregates represented an 
indirect consequence of a radical drop in protein levels (see ‘Discussion’). We note that the observed 
drop in Sup35 NM-mCherry-His6x fusion protein levels is not irreversible, as exemplified by L2E, which 
exhibited a loss of detectable Sup35 NM aggregates coincident with an R3 drop in fusion protein 
levels and an apparent restoration of fusion protein levels by R4 in all 10 samples (Figure 4—figure 
supplement 1A). Despite the presence of normal levels of fusion protein, SDS-stable Sup35 NM 
aggregates were not recovered in R4 of L2E, consistent with the expectation that prion propagation 
requires that prion protein synthesis be maintained above some threshold level (Figure 4—figure 
supplement 1A, Figure 5A; Holmes et al., 2013). Critically, none of the samples (120 in total) from 
any of the four control lineages contained detectable SDS-stable Sup35 NM aggregates (Figure 4B, 
Figure 4—figure supplement 2).
Figure supplement 1. α-Sup35 and α-His6X antibodies are interchangeable for detecting the Sup35 
NM-mCherry-His6X fusion protein. 
DOI: 10.7554/eLife.02949.004
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Figure 2. Experimental protocol for assessing the ability of E. coli cells to propagate SDS-stable Sup35 NM 
aggregates. Experiments are initiated with either a starter culture (ST) of cells containing Sup35 NM and New1 
(shown) or a starter culture of cells containing Sup35 NM alone (not shown). For each of the 4 lineages (L1–L4), the 
Figure 2. Continued on next pageMicrobiology and infectious disease
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Fluorescence microscopy revealed that cells containing propagated Sup35 NM aggregates exhibited 
smaller foci emanating from large aggregates typically localized at cell poles, a phenotype distin-
guished from experimental starter culture cells by the lack of twisted ring structures (Figure 5C). 
However, we observed one instance of aggregate-positive R1 cells exhibiting twisted ring structures 
(see Figure 6—figure supplement 2C). Whereas we cannot definitively assign the SDS-stable Sup35 
NM aggregates detected by filter retention to those structures detected by fluorescence microscopy, 
we note that fluorescence microscopy of prion-containing yeast cells has also revealed structural diver-
sity (Derkatch et al., 2001; Zhou et al., 2001). Furthermore, cells from aggregate-negative samples 
invariably exhibited diffuse fluorescence (Figure 5D).
Propagated SDS-stable Sup35 NM aggregates are infectious when 
introduced into [psi−] yeast cells
We next sought to determine whether cells that maintained SDS-stable Sup35 NM aggregates in the 
absence of New1 contained infectious material capable of converting [psi−] yeast cells to [PSI+]. We 
prepared bacterial cell extracts from both experimental and control starter cultures, as well as aggre-
gate-positive samples from each of the four experimental lineages. For each experimental lineage, we 
examined an arbitrarily chosen sample obtained from the last aggregate-positive round. In addition, 
for L2E and L4E, we examined, respectively, the R2 and R3 samples (indicated by asterisks in Figure 5E) 
that gave rise to aggregate-negative clones in the subsequent round. We used these bacterial extracts 
to transform S. cerevisiae spheroplasts prepared from a [pin−][psi−] strain. The use of a [pin−] recipient 
strain was critical as transient overproduction of Sup35 (or Sup35 NM) in [PIN+][psi−] strains significantly 
stimulates the conversion from [psi−] to [PSI+] (Derkatch et al., 1997), whereas conversion in a [pin−]
[psi−] background requires the introduction of infectious seed material (Tanaka and Weissman, 2006).
The experimental starter culture yielded [PSI+] yeast transformants at a frequency of ∼1% (Figure 
5E), consistent with our previous findings (Garrity et al., 2010). Similarly, each of the aggregate-pos-
itive samples from the four experimental lineages yielded [PSI+] yeast transformants at a frequency of 
∼1%; in contrast, the aggregate-negative samples yielded no [PSI+] yeast transformants (Figure 5E). 
Among the [PSI+] transformants we obtained with the experimental samples, we observed both 
‘strong’ and ‘weak’ strains (Figure 5—figure supplement 1; Tanaka et al., 2004; Frederick et al., 
2014). We note that ∼1% corresponds only to the frequency of strong [PSI+] transformants and there-
fore represents a conservative estimate of E. coli cell extract infectivity; we did not attempt to quantify 
weak [PSI+] transformants because they are difficult to distinguish from [psi−] transformants on the 
medium utilized to isolate transformants. We conclude that E. coli cells can propagate Sup35 NM in 
an infectious prion conformation over at least ∼100 generations under conditions that do not permit 
de novo prion formation.
Propagation of infectious Sup35 NM aggregates depends on ClpB
The propagation of [PSI+] and other prions in yeast requires Hsp104, an Hsp100-family ATP-dependent 
disaggregase that functions as a ring-shaped hexamer. Specifically, Hsp104 is thought to facilitate 
prion propagation by fragmenting large aggregates into smaller propagons that are subsequently dis-
seminated during cell division (Paushkin et al., 1996; Ness et al., 2002; Cox et al., 2003; Kryndushkin 
et al., 2003; Satpute-Krishnan et al., 2007; Higurashi et al., 2008). We therefore investigated 
whether or not the propagation of Sup35 NM aggregates in E. coli requires ClpB, the bacterial 
ortholog of Hsp104. To address this question, we sought to deplete cells of ClpB specifically during 
the propagation phase of our experiments. To accomplish this, we modified pSC101TS-NEW1 such that 
total number of generations over which Sup35 NM prion propagation is monitored corresponds to the number of 
cell divisions that occur in the absence of New1 during 4 rounds (R1–R4) of growth on solid medium and an 
additional round of growth in liquid medium. Growth in the absence of New1 begins at the time the starter culture 
cells are plated at 37°C (R1). Single R1 colonies were found to contain ∼950,000 colony forming units (CFUs), and 
the liquid cultures contain ∼108 CFUs per μl. Thus, prion propagation is monitored over 98.7 or ∼100 generations. 
We note that the presence of SDS-stable Sup35 NM aggregates in experimental starter culture cells does not 
represent prion propagation because the presence of New1 (i.e., [PIN+]) enables the continuing de novo conversion 
of newly synthesized Sup35 NM to the prion form.
DOI: 10.7554/eLife.02949.005
Figure 2. ContinuedMicrobiology and infectious disease
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it also directed the expression of clpB under the control of its native promoter. When transformed into 
ΔclpB cells, pSC101TS-NEW1-clpB enabled us to grow starter cultures containing ClpB and subsequently 
to deplete both ClpB and New1 in cells plated at the non-permissive temperature (Figure 6A).
As expected, we detected SDS-stable Sup35 NM aggregates in ΔclpB starter culture cells trans-
formed with pBR322-SUP35 NM and pSC101TS-NEW1-clpB (Figure 6—figure supplement 1A). 
Furthermore, fluorescence microscopy revealed that these cells contained visible aggregates that were 
nearly indistinguishable from those in wild-type cells containing pBR322-SUP35 NM and pSC101TS-NEW1 
(Figure 6—figure supplement 1B). After plating ΔclpB starter culture cells containing pBR322-SUP35 
Figure 3. Converted Sup35 NM can remain in its prion conformation in E. coli cells lacking New1. (A) Cartoon 
representation of how Sup35 NM can convert to its prion form in the presence of New1 and remain in the prion 
conformation after cells have been cured of New1-encoding DNA. Sup35 NM and New1 (black) are depicted as 
fusions to mCherry (red) and mGFP (green), respectively. (B) SDS-stable Sup35 NM aggregates are detected in 8 of 
20 Round 1 (R1) experimental clones derived from a starter culture (ST) of cells containing Sup35 NM and New1 as 
assessed by filter retention analysis. Starter cultures of cells containing Sup35 NM and New1 and cells containing 
Sup35 NM alone serve as positive (P) and negative (N) controls, respectively. The four aggregate-positive clones 
selected to establish the four experimental lineages are indicated by asterisks. In all 20 R1 experimental samples, 
intracellular Sup35 NM fusion protein levels are comparable, and New1 fusion protein is not detectable as assessed 
by Western blot analysis. The α-His6X and α-Sup35 antibodies recognize the Sup35 NM-mCherry-His6X fusion 
protein (see Figure 1—figure supplement 1B,C), the α-GFP antibody detects the New1-mGFP fusion protein, and 
the α-RpoA antibody recognizes the α subunit of E. coli RNA polymerase. (C) In all 20 R1 experimental samples, 
DNA encoding Sup35 NM is detectable whereas DNA encoding the prionogenic module of New1 is not detecta-
ble by PCR. (D) SDS-stable Sup35 NM aggregates are not detected in any of the 20 R1 control clones derived from 
a starter culture of cells containing Sup35 NM alone as assessed by filter retention analysis. The four aggregate-
negative clones selected to establish the four control lineages are indicated by asterisks. Intracellular Sup35 NM 
fusion protein levels are comparable in all 20 R1 control samples.
DOI: 10.7554/eLife.02949.006Microbiology and infectious disease
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Figure 4. E. coli can propagate the Sup35 NM prion over ∼100 generations. (A) Experimental Lineage 1 (L1E). An 
aggregate-positive Round 1 (R1) experimental clone (gray box) derived from a starter culture (ST) of cells contain-
ing Sup35 NM and New1 is identified and restreaked to yield progeny Round 2 (R2) clones (gray bracket). All 10 R2 
clones analyzed contain detectable SDS-stable Sup35 NM aggregates. An aggregate-positive R2 clone (blue box) 
is identified and restreaked to yield progeny Round 3 (R3) clones (blue bracket). Again, all 10 R3 clones analyzed 
contain SDS-stable Sup35 NM aggregates. An aggregate-positive R3 clone (green box) is identified and restreaked 
to yield progeny Round 4 (R4) clones (green bracket). 9 of 10 R4 clones analyzed contain SDS-stable Sup35 NM 
aggregates. The filter retention assay is used to detect SDS-stable Sup35 NM aggregates. Intracellular Sup35 NM 
fusion protein levels are comparable in all 40 samples as assessed by Western blot analysis. Starter cultures of cells 
containing Sup35 NM and New1 and cells containing Sup35 NM alone serve as positive (P) and negative (N) 
controls, respectively. The α-His6X and α-Sup35 antibodies recognize the Sup35 NM-mCherry-His6X fusion protein, 
and the α-RpoA antibody recognizes the α subunit of E. coli RNA polymerase. (B) Control Lineage 1 (L1C). An 
Figure 4. Continued on next pageMicrobiology and infectious disease
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NM and pSC101TS-NEW1-clpB at the non-permissive temperature to cure cells of ClpB- and New1-
encoding DNA, we examined 60 R1 colonies for the presence of SDS-stable Sup35 NM aggregates. In 
parallel, we examined 60 R1 colonies derived from wild-type starter culture cells containing pBR322-
SUP35 NM and pSC101TS-NEW1. As before, every selected colony was patched onto selective medium   
to test for the loss of pSC101TS-NEW1-clpB or pSC101TS-NEW1 and inoculated into liquid medium for 
overnight growth to test for the presence of SDS-stable Sup35 NM aggregates. All selected colonies 
had lost the appropriate temperature-sensitive vector and the absence of New1 and/or ClpB was 
confirmed by Western blot analysis (Figure 6B, Figure 6C). Whereas 17 of 60 (28%) wild-type R1 samples 
tested aggregate-positive, all ΔclpB R1 samples tested aggregate-negative (Figure 6B, Figure 6—figure 
supplement 2A, Figure 6C, Figure 6—figure supplement 2B). Western blot analysis revealed that 
the wild-type and ΔclpB R1 cells contained comparable amounts of Sup35 NM fusion protein (Figure 6B, 
Figure 6C). Furthermore, yeast transformation assays confirmed the presence of infectious material 
capable of converting [psi−] yeast cells to [PSI+] in ΔclpB starter culture cells transformed with pBR322-
SUP35 NM and pSC101TS-NEW1-clpB as well as in an aggregate-positive R1 clone derived from wild-
type starter culture cells (Figure 6D). In contrast, a ΔclpB R1 clone derived from ΔclpB starter culture 
cells containing pBR322-SUP35 NM and pSC101TS-NEW1-clpB as well as an aggregate-negative R1 
clone derived from wild-type starter culture cells containing pBR322-SUP35 NM and pSC101TS lacked 
detectable infectivity (Figure 6D). We conclude that cells lacking ClpB cannot propagate Sup35 NM 
in its infectious prion conformation.
ClpB disaggregase activity is required for propagation of SDS-stable 
Sup35 NM aggregates
To investigate the mechanistic basis for the ClpB dependence of Sup35 NM prion propagation in 
E. coli, we devised a strategy that enabled us to test the abilities of specific ClpB mutants to support 
the propagation of SDS-stable Sup35 NM aggregates after their formation in the presence of wild-
type ClpB. The disaggregase function of ClpB, which assembles as a two-tiered hexameric ring (Lee 
et al., 2003), depends on its abilities to hydrolyze ATP, to translocate polypeptides through its central 
pore and to collaborate with DnaK (the bacterial Hsp70) and its co-chaperones DnaJ and the nucleo-
tide exchange factor GrpE (reviewed in Doyle and Wickner, 2009). Accordingly, we tested previously 
characterized ClpB mutants specifically defective for (i) ATP hydrolysis (E279A/E678A) (Weibezahn et 
al., 2003) (ii) substrate threading through the ClpB pore (Y653A) (Weibezahn et al., 2004), and (iii) 
collaboration with DnaK (E432A) (Oguchi et al., 2012; Seyffer et al., 2012; Carroni et al., 2014). We 
note that each of these ClpB mutants is fully proficient for oligomerization and only ClpB E279A/
E678A is deficient in ATPase activity (Mogk et al., 2003; Weibezahn et al., 2004; Oguchi et al., 
2012). Our strategy required us to construct strains in which we could induce the production of a ClpB 
mutant specifically during the propagation phase of the experiment while providing wild-type ClpB 
during the formation phase of the experiment only. To accomplish this, we placed each of the mutant 
clpB alleles (or the wild-type allele) under the control of the anhydrotetracycline (aTc)-inducible pro-
moter PLtetO-I (Lutz and Bujard, 1997), integrated these constructs onto the chromosome of our ΔclpB 
strain, and transformed the resulting strains with pBR322-SUP35 NM and pSC101TS-NEW1-clpB.
As expected, we detected SDS-stable Sup35 NM aggregates in starter culture cells of all strains 
producing plasmid-encoded Sup35 NM-mCherry-His6X, New1-mGFP, and wild-type ClpB (Figure 7A). 
aggregate-negative R1 control clone (gray box) derived from a starter culture of cells containing Sup35 NM alone is 
identified and restreaked to yield progeny R2 clones (gray bracket), an aggregate-negative R2 clone (blue box) is 
identified and restreaked to yield progeny R3 clones (blue bracket), and an aggregate-negative R3 clone (green 
box) is identified and restreaked to yield progeny R4 clones (green bracket). No SDS-stable Sup35 NM aggregates 
are detectable in any sample. Intracellular Sup35 NM fusion protein levels are comparable in all 40 samples as 
assessed by Western blot analysis.
DOI: 10.7554/eLife.02949.007
The following figure supplements are available for figure 4:
Figure supplement 1. The fate of Sup35 NM in experimental Lineages 2-4. 
DOI: 10.7554/eLife.02949.008
Figure supplement 2. The fate of Sup35 NM in control Lineages 2–4. 
DOI: 10.7554/eLife.02949.009
Figure 4. ContinuedMicrobiology and infectious disease
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Figure 5. Genealogy of E. coli cell lineages propagating Sup35 NM in an infectious prion conformation. (A) The 
fate of Sup35 NM in four experimental lineages (L1E-L4E) established from a starter culture of cells containing Sup35 
NM and New1 is shown. Clones that maintain or lose the Sup35 NM prion are indicated by black or pink lines, 
respectively. Rounds 1–4 (R1–R4) are depicted as gray arcs, with R1 situated at the center of the tree. Clones are 
designated as aggregate-positive if they contain SDS-stable Sup35 NM aggregates that are detectable in the 
undiluted sample and at least 1 of the 3 two-fold serial dilutions, as analyzed by filter retention. L1E and L3E retain 
SDS-stable Sup35 NM aggregates for the duration of the experiment (Figure 4A, Figure 4—figure supplement 1B). 
L2E and L4E lose detectable SDS-stable Sup35 NM aggregates at R3 and R4, respectively. In both cases, the loss of 
SDS-stable aggregates coincides with a dramatic yet apparently reversible drop in fusion protein levels (Figure 
4—figure supplement 1A,C; see ‘Discussion’). Cells from four aggregate-positive L1E-R4 clones visualized by 
fluorescence microscopy are indicated by asterisks. (B) The fate of Sup35 NM in four control lineages (L1C–L4C) 
established from a starter culture of cells containing Sup35 NM alone is shown. None of the 120 clones analyzed 
Figure 5. Continued on next pageMicrobiology and infectious disease
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To determine whether or not each of the mutants could support the propagation of these aggregates 
following the depletion of New1 and wild-type ClpB, we plated the starter culture cells at the nonpermis-
sive temperature on solid medium lacking or containing increasing concentrations of aTc, generating sets 
of R1 colonies. We prepared cell extracts from scraped R1 colonies (‘Materials and methods’) and exam-
ined these extracts for the presence or absence of SDS-stable Sup35 NM aggregates. Whereas SDS-stable 
Sup35 NM aggregates were detected as a function of increasing aTc concentration in cells carrying the 
wild-type clpB allele, no aggregates were detected in cells harboring the clpB E279A/E678A, clpB Y653A, 
or clpB E432A allele at any concentration of aTc (Figure 7A). Western blot analysis revealed that levels of 
chromosomally-encoded wild-type ClpB and each of the three disaggregase mutants were comparable in 
cell extracts prepared from colonies scraped off of plates containing 50 ng/ml aTc (Figure 7B). Furthermore, 
replica plating confirmed that all colonies of R1 cells grown on medium supplemented with 50 ng/ml 
aTc had been cured of pSC101TS-NEW1-clpB (Figure 7—figure supplement 1). We conclude that 
ATP hydrolysis coupled to substrate translocation through the ClpB central pore and collaboration 
with DnaK are required for propagation of SDS-stable Sup35 NM aggregates in the absence of New1.
Discussion
Our findings establish that bacteria can propagate a prion. This is, to our knowledge, the first formal 
demonstration of prion propagation in a non-eukaryote. More specifically, the [PIN+]-dependent de 
novo conversion of Sup35 NM to its prion form in our E. coli system enabled us to distinguish experi-
mentally between the initial formation phase and subsequent propagation phase of the prion cycle. 
Under our experimental conditions, two of four cell lineages (L1E and L3E) maintained the prion for the 
duration of the experiment (that is, ∼100 generations), one lineage (L4E) maintained the prion for ∼80 
generations, and one lineage (L2E) maintained the prion for ∼60 generations. Furthermore, our work 
demonstrates that prion propagation in E. coli requires the disaggregase activity of ClpB, the bacterial 
ortholog of Hsp104. We conclude that bacteria can support a chaperone-dependent, protein-based 
mode of heredity and speculate that the emergence of prion-like phenomena may have predated the 
evolutionary split between eukaryotes and bacteria.
Stability of prion propagation in E. coli
As only two of four lineages retained the prion for the full duration of our experiments, propagation 
of the Sup35 NM prion may be less stable in E. coli than in S. cerevisiae (DiSalvo et al., 2011). 
However, as noted above, loss of the prion in two lineages was coincident with a dramatic drop in 
Sup35 NM fusion protein levels. Furthermore, this drop was evidently reversible as Sup35 NM fusion 
protein levels were restored in R4 of L2E without reappearance of the prion. We do not understand the 
contain SDS-stable Sup35 NM aggregates (Figure 4B, Figure 4—figure supplement 2). Cells from four aggre-
gate-negative L1C-R4 clones visualized by fluorescence microscopy are indicated by asterisks. (C) Fluorescence 
images of representative cells corresponding to the four aggregate-positive R4 clones indicated by asterisks in (A). 
(D) Fluorescence images of representative cells corresponding to the four aggregate-negative R4 clones indicated 
by asterisks in (B). (E) E. coli cell extracts containing propagated, SDS-stable Sup35 NM aggregates are infectious 
when transformed into S. cerevisiae [psi−] cells. A starter culture (ST) of cells containing Sup35 NM and New1 
contain infectious SDS-stable Sup35 NM aggregates capable of converting [psi−] yeast cells to [PSI+]. In contrast, a 
starter culture of cells containing Sup35 NM alone lacks detectable infectivity. Progeny cell extracts transformed 
into yeast are identified as RX-Y, where X corresponds to a round number and Y corresponds to a clone number 
assigned sequentially and clockwise according to (A) and (B). Clones that gave rise to aggregate-negative progeny 
in the subsequent round are indicated by asterisks. Analysis of these data by Fisher's exact test indicates that the 
differences in the frequency of [PSI+] transformants observed with samples containing SDS-stable Sup35 NM 
aggregates compared with the sample containing soluble Sup35 NM are statistically significant (p < 0.0001). The 
percentages given refer to strong [PSI+] transformants; samples containing SDS-stable Sup35 NM aggregates (but 
not samples containing soluble Sup35 NM) also gave rise to weak [PSI+] transformants (Figure 5—figure supple-
ment 1), but these were not quantified (‘Results’).
DOI: 10.7554/eLife.02949.010
The following figure supplement is available for figure 5:
Figure supplement 1. Bacterial cell extracts containing propagated, infectious Sup35 NM aggregates yield both 
strong and weak [PSI+] yeast transformants. 
DOI: 10.7554/eLife.02949.011
Figure 5. ContinuedMicrobiology and infectious disease
Yuan et al. eLife 2014;3:e02949. DOI: 10.7554/eLife.02949  13 of 19
Research article
Figure 6. Sup35 NM prion propagation in E. coli requires ClpB. (A) Cartoon representation of how Sup35 NM can 
convert to its prion form in the presence of New1 and ClpB but cannot propagate in the prion conformation after 
cells have been cured of New1- and ClpB-encoding DNA. Sup35 NM and New1 (black) are depicted as fusions to 
mCherry (red) and mGFP (green), respectively. ClpB is depicted as a purple hexamer. (B) SDS-stable Sup35 NM 
aggregates are detected in 5 of 20 Round 1 (R1) wild-type (WT) clones derived from a starter culture (ST) of 
wild-type cells containing Sup35 NM and New1 as assessed by filter retention analysis. In total, 17 of 60 R1 
wild-type clones are aggregate-positive (Figure 6—figure supplement 2A). Starter cultures of cells containing 
Sup35 NM and New1 and cells containing Sup35 NM alone serve as positive (P) and negative (N) controls, 
respectively. In all 20 R1 wild-type clones shown, full-length (FL) ClpB is detectable, Sup35 NM fusion protein levels 
are comparable, and New1 fusion protein is not detectable as assessed by Western blot analysis. The α-His6X and 
α-Sup35 antibodies recognize the Sup35 NM-mCherry-His6X fusion protein, the α-GFP antibody recognizes the 
New1–mGFP fusion protein, the α-ClpB antibody recognizes the E. coli ClpB chaperone, and the α-RpoA antibody 
recognizes the α subunit of E. coli RNA polymerase. Cells from four aggregate-positive R1 wild-type clones 
visualized by fluorescence microscopy (Figure 6—figure supplement 2C) are indicated by asterisks. (C) SDS-stable 
Sup35 NM aggregates are not detectable in R1 ΔclpB clones derived from a starter culture of ΔclpB cells contain-
ing Sup35 NM, New1, and ectopically produced ClpB as assessed by filter retention analysis. In total, 0 of 60 R1 
ΔclpB clones are aggregate-positive (Figure 6—figure supplement 2B). Starter cultures of wild-type cells 
containing Sup35 NM and New1 and wild-type cells containing Sup35 NM alone serve as positive (P) and negative 
(N) controls, respectively. In all 20 R1 ΔclpB clones shown, Sup35 NM fusion protein levels are comparable, and 
neither ClpB nor New1 fusion protein is detectable as assessed by Western blot analysis. Cells from four aggre-
gate-negative R1 wild-type clones visualized by fluorescence microscopy (Figure 6—figure supplement 2D)  
are indicated by asterisks. (D) Extract prepared from cells lacking ClpB is not infectious when transformed into  
Figure 6. Continued on next pageMicrobiology and infectious disease
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mechanism underlying this reversible change in protein levels; however, we suggest that stochastic 
fluctuations in plasmid copy number may set the stage for such an event. We note that our experi-
ments were performed in recA− cells, which should prevent plasmid rearrangements that might lead 
to a permanent loss of fusion protein coding capacity.
Bacterial machinery capable of remodeling Sup35 NM aggregates
The question of whether or not ClpB can substitute for Hsp104 in promoting Sup35 prion propagation 
has been addressed in a number of studies yielding conflicting indications. On one hand, several in 
vitro studies have provided evidence that Hsp104 (Shorter and Lindquist, 2004,  2006,  2008; 
DeSantis et al., 2012), but not ClpB (DeSantis et al., 2012), can fragment amyloid aggregates in the 
absence of auxiliary factors. Furthermore, whereas the presence of various combinations of S. cerevi-
siae Hsp70- and Hsp40-family proteins was found to modulate Hsp104 activity on amyloid substrates 
(Shorter and Lindquist, 2008; DeSantis et al., 2012), ClpB appeared to remain inert even in the 
presence of bacterial Hsp70 (DnaK), Hsp40 (DnaJ), and nucleotide exchange factor GrpE despite 
exhibiting robust activity on various disordered protein aggregates in vitro (DeSantis et al., 2012).
On the other hand, the results of several in vivo studies suggest that ClpB, in the presence of ap-
propriate co-chaperones, is competent to support Sup35 prion propagation in yeast (Tipton et al., 
2008; Reidy et al., 2012). Based on an analysis of the in vivo activities of Hsp104/ClpB chimeras, 
Tipton et al. argue that prion replication in yeast requires that Hsp104 collaborate with its cognate 
Hsp70 chaperone system. A logical inference from their work is that the inability of ClpB to substitute 
for Hsp104 in supporting Sup35 prion propagation in S. cerevisiae is an indirect consequence of the 
inability of ClpB to cooperate with fungal co-chaperones. More recently, Reidy et al. provided direct 
support for this inference. In particular, Reidy et al. found that ClpB supported prion propagation in 
yeast provided that DnaK and GrpE were present. Interestingly, the activity of the bacterial disaggre-
gase machinery in yeast was dependent on the fungal Hsp40-family Sis1 protein, consistent with prior 
work implicating Sis1 as a necessary component of the chaperone network required for prion propa-
gation in yeast (Higurashi et al., 2008; Tipton et al., 2008). Our work demonstrates that no exoge-
nous fungal accessory factors are required for prion propagation in bacteria. Taken together, these 
observations argue that the amyloid remodeling activity of Hsp104 is an evolutionarily conserved 
feature of the Hsp100-family chaperones, an inference that is strongly supported by our finding that 
propagation of the Sup35 NM prion in E. coli requires ClpB disaggregase activity.
Despite the apparent prevalence of prions in the fungal kingdom, to date, no bacterial prion has 
been identified. Notably, the absence of cytoplasmic mixing during conjugation would preclude the 
discovery of prion-like phenomena by classic genetic approaches, which facilitated the discovery of 
prions in yeast based on the non-Mendelian inheritance of their associated phenotypes (Cox, 1965; 
Aigle and Lacroute, 1975; Wickner, 1994). Nevertheless, recent bioinformatic analyses of prokaryotic 
proteomes have revealed that bacterial and archaeal genomes encode many proteins containing 
glutamine- and asparagine-rich prion-like domains resembling those found in most confirmed and 
putative S. cerevisiae prions (Alberti et al., 2009; Espinosa Angarica et al., 2013; Yuan et al., 
S. cerevisiae [psi–] cells. Starter cultures of wild-type cells transformed with pBR322-SUP35 NM and pSC101TS-NEW1 
as well as ΔclpB cells transformed with pBR322-SUP35 NM and pSC101TS-NEW1-clpB contain infectious SDS-stable 
Sup35 NM aggregates capable of converting [psi−] yeast cells to [PSI+]. Wild-type starter culture cells containing 
Sup35 NM alone lack detectable infectivity. An aggregate-positive R1 wild-type clone retains infectious Sup35 NM 
aggregates. In contrast, an aggregate-negative R1 ΔclpB clone lacks detectable infectivity, as does an aggregate-
negative R1 wild-type clone. Analysis of these data by Fisher's exact test indicates that the differences in the 
frequency of [PSI+] transformants observed with samples containing SDS-stable Sup35 NM aggregates compared 
with the samples containing soluble Sup35 NM are statistically significant (p < 0.0001).
DOI: 10.7554/eLife.02949.012
The following figure supplements are available for figure 6:
Figure supplement 1. ΔclpB cells containing New1 and ectopically produced ClpB support the formation of 
SDS-stable Sup35 NM aggregates. 
DOI: 10.7554/eLife.02949.013
Figure supplement 2. The fate of Sup35 NM in 40 wild-type R1 clones and 40 ΔclpB R1 clones. 
DOI: 10.7554/eLife.02949.014
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unpublished data). Moreover, it is becoming   
increasingly clear that Q/N-richness at the level of 
primary amino acid sequence is neither a prereq-
uisite for prion conversion (Taneja et al., 2007; 
Suzuki et al., 2012) nor protein amyloidogenesis 
(Goldschmidt et al., 2010). In fact, several bacteria 
utilize non-Q/N-rich amyloid-forming proteins to 
assemble extracellular appendages mediating 
surface attachment and biofilm formation 
(Chapman et al., 2002; Romero et al., 2010). 
These considerations—in conjunction with the work 
presented here—suggest that prions or prion-like 
proteins may exist as epigenetic reservoirs of phe-
notypic diversity in the bacterial domain of life.
Materials and methods
Strains, plasmids, and cell growth
Bacteria experiments were performed with E. coli 
strain DH5αZ1 (Lutz and Bujard, 1997) grown in 
LB (Miller) medium. To construct DH5αZ1 ΔclpB, 
a temperature-sensitive plasmid encoding the 
RecA protein (pSC101TS-recA) was constructed 
and transformed into DH5αZ1 cells. A ΔclpB::kan 
allele from strain JW2573 (Keio collection) was 
transferred to DH5αZ1 cells containing pSC101TS-
recA via P1 transduction. Cells were subsequently 
cured of pSC101TS-recA by overnight growth and 
plating in the absence of antibiotic selection at 
the non-permissive temperature (37°C).
To construct strains harboring chromosomal 
PLtetO-I-clpB alleles, plasmids pAY152, pAY154, 
pAY155, pAY156, and pAY157 were cloned in 
strain AY290 and integrated onto the chromosome 
of strain AY295 at attB(HK022). Single-copy inte-
grants were selected on LB agar supplemented 
with kanamycin (10 μg/ml) and verified by PCR 
as described (Haldimann and Wanner, 2001).
Yeast experiments were performed with   
S. cerevisiae strain YJW187 [pin−][psi−] grown in 
yeast extract peptone dextrose (YPD) medium. 
For yeast infectivity assays, cell extracts were co-
transformed with pRS316 into YJW187 sphero-
plasts; [PSI+] URA+ transformants were identified 
by plating the yeast cells in top agar containing 
synthetic defined medium lacking uracil and   
adenine (SD-Ura-Ade) and supplemented with 
10 mg/ml adenine hemisulfate (Sunrise Science, 
San Diego, CA).
Further details concerning strains and plasmids 
are provided in Supplementary file 1.
Propagation experiments
Cells were transformed with pBR322-SUP35 NM 
and pSC101TS, pSC101TS-NEW1, or pSC101TS-
NEW1-clpB and grown at 30°C on LB agar 
Figure 7. Propagation of SDS-stable Sup35 NM 
aggregates in E. coli requires ClpB disaggregase activity. 
(A) SDS-stable Sup35 NM aggregates are detected in 
starter cultures (ST) of ΔclpB cells containing pBR322-
SUP35 NM, pSC101TS-NEW1-clpB, and one of four 
aTc-inducible chromosomal clpB alleles. Wild-type (WT) 
ClpB is depicted as a purple hexamer. ClpB E279A/
E678A is unable to hydrolyze ATP, ClpB Y653A is 
pore-deficient, and ClpB E432A is unable to collaborate 
with DnaK. Propagated Sup35 NM aggregates are 
detected in scraped cell suspensions as a function of 
increasing aTc concentration only for Round 1 (R1) clones 
producing wild-type ClpB. Sup35 NM aggregates are 
not detected at any aTc concentration in scraped cell 
suspensions of R1 clones producing ClpB disaggregase 
mutants or in R1 clones lacking ClpB. Lanes cropped 
from the same immunoblot are indicated by hash 
marks. The α-His6X antibody recognizes the Sup35 
NM-mCherry-His6X fusion protein. (B) Wild-type and 
mutant ClpB levels along with Sup35 NM fusion protein 
levels are comparable in R1 clones grown on solid 
medium supplemented with 50 ng/ml aTc as assessed 
by Western blot analysis. The α-Sup35 antibody 
recognizes the Sup35 NM-mCherry-His6X fusion protein, 
the α-GFP antibody recognizes the New1-mGFP fusion 
protein, the α-ClpB antibody recognizes the E. coli 
ClpB chaperone, and the α-RpoA antibody recognizes 
the α subunit of E. coli RNA polymerase.
DOI: 10.7554/eLife.02949.015
The following figure supplement is available for figure 7:
Figure supplement 1. All Round 1 clones producing 
wild-type ClpB are cured of pSC101TS-NEW1-clpB. 
DOI: 10.7554/eLife.02949.016Microbiology and infectious disease
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supplemented with carbenicillin (Carb, 100 μg/ml) and chloramphenicol (Cam, 12.5 μg/ml). Starter 
cultures were generated by growing transformants at 30°C in 6 ml of LB broth supplemented with 
Carb (100 μg/ml), Cam (12.5 μg/ml), and 10 μM IPTG to an OD600 of 2.0–2.5. To cure cells of pSC101TS-
derivatives and generate Round 1 (R1) colonies, starter cultures were diluted (10−5) in pre-warmed 
(37°C) LB broth supplemented with Carb (100 μg/ml) and 10 μM IPTG. Diluted cells were grown at 
37°C on pre-warmed (37°C) LB agar supplemented with Carb (100 μg/ml) and 10 μM IPTG. R1–R4 
colonies were, (a) patched on LB agar supplemented with Cam (12.5 μg/ml), (b) restreaked and grown 
at 30°C on pre-warmed (30°C) LB agar supplemented with Carb (100 μg/ml) and 10 μM IPTG, and (c) 
inoculated and grown at 30°C in 6 ml LB broth supplemented with Carb (100 μg/ml) and 10 μM IPTG. 
For analysis of ClpB disaggregase mutants, ∼1000 R1 colonies were gently scraped off LB agar plates 
containing Carb (100 μg/ml), 10 μM IPTG, and a range of aTc concentrations (0–500 ng/ml) in 3 ml LB 
broth supplemented with Carb (100 μg/ml) and 10 μM IPTG.
Cell cultures and scraped cell suspensions were normalized to 8 ml of an OD600 of 1.0 and pelleted 
by centrifugation. Cell pellets were resuspended in 166 ml STC Buffer (1 M sorbitol, 10 mM Tris–HCl 
[pH 7.5], 10 mM CaCl2) supplemented with 10 U of rLysozme (Novagen, Germany) and 0.1 U of 
OmniCleave endonuclease (Epicentre, Wisconsin, MA), incubated at room-temperature for 30 min, 
and incubated on ice for an additional 30 min. Omnicleave endonuclease was omitted from samples 
destined for PCR analysis and yeast infectivity assays. Finally, samples were flash frozen and thawed on 
ice to yield unclarified lysates (used in filter retention assays). To generate partially clarified lysates 
(used in Western blot analysis and yeast transformation assays), unclarified lysates were subjected to 
two rounds of low-speed centrifugation, each at 500 RCF for 15 min at 4°C.
Filter retention assays
25 μl of unclarified lysates was added to 375 μl of BugBuster protein extraction reagent (Novagen) 
supplemented with 5 U of rLysozyme and 0.1 U of Omnicleave endonuclease and gently rocked at 
room-temperature for 30 min. Samples were challenged with 100 μl of 10% (wt/vol) SDS (2% SDS 
final concentration) and gently rocked at room-temperature for an additional 30 min. For each sample, 
100 μl of undiluted lysate and three twofold serial dilutions made in PBS containing 2% SDS were 
filtered through a 0.2-μm cellulose acetate membrane (Advantec, Japan) in a dot-blotting vacuum 
manifold. Samples on membranes were washed twice with 100 μl of PBS containing 2% SDS and 
twice with 100 μl of PBS.
Immunoblotting
Cellulose acetate membranes (used in filter retention assays) and Hybond-C Extra nitrocellulose mem-
branes (used in Western blot analysis) were blocked for 30 min in PBS containing 3% (wt/vol) milk. 
Membranes were probed with one of the following primary antibodies: anti-Sup35 (yS-20, Santa Cruz 
Biotechnology, Dallas, TX, 1:5000), anti-His6X (His-2; Roche, Indianapolis, IN, 1:10,000), anti-GFP 
(Roche, 1:10,000), anti-RpoA (NeoClone, Madison, WI, 1:10,000), or anti-ClpB (gift from S Wickner, 
1:10,000). Membranes were washed and probed with one of the following HRP-conjugated sec-
ondary antibodies: anti-goat IgG (Santa Cruz Biotechnology, 1:10,000), anti-mouse IgG (Cell Signaling, 
Beverly, MA, 1:10,000), or anti-rabbit IgG (Cell Signaling, 1:10,000). Proteins were detected with 
ECL Plus Western blot detection reagents (GE Healthcare, Pittsburgh, PA) and a ChemiDock XRS+ 
imaging system (Bio-Rad, Hercules, CA).
Yeast infectivity assays
Protein concentrations of partially clarified E. coli cell extracts were determined by the bicinchoninic 
acid (BCA) assay (ThermoFisher, Waltham, MA) and normalized to ∼1 mg/ml. Protein transforma-
tions were performed as previously described (Tanaka and Weissman, 2006; Garrity et al., 2010). 
Each and every putative [PSI+] transformant was (a) restreaked on 1/4 YPD agar to assess the [PSI+] 
phenotype, (b) restreaked on YPD containing 3 mM GuHCl to cure cells of [PSI+], and (c) restreaked 
on 1/4 YPD to assess the [psi−] phenotype. Only those transformants exhibiting curability were scored 
as [PSI+].
Fluorescence microscopy
Cells were spotted onto 1% (wt/vol) agarose pads consisting of Seakem LE Agarose (Lonza, 
Walkersville, MD) in PBS and visualized with an UplanFL N 100x/1.30 phase contrast objective Microbiology and infectious disease
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mounted on an Olympus BX61 microscope. Images were captured with a CoolSnapHQ camera 
(Photometrics, Tucson, AZ) and the Metamorph software package (Molecular Devices, Sunnyvale, 
CA). All fluorescence images were obtained from 10 ms exposures.
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